The Latest in Oncology Practice

No benefit from dual anti-HER2 blockade in early breast cancer

November 23, 2015

Breast Cancer

Alectinib shows promise in crizotinib-refractory ALK-rearranged NSCLC

November 23, 2015

Lung Cancer

No racial disparity in appropriate use of Oncotype DX

November 23, 2015

Breast Cancer

Stark Law: More flexibility starting in 2016

November 23, 2015

Practice Management

Dermatologists’ management of melanoma varies

November 21, 2015

Melanoma

Ixazomib approved for multiple myeloma combo treatment

November 20, 2015

Leukemia, Myelodysplasia, Transplantation

Hold the checkpoint inhibitors when pneumonitis symptoms occur

November 20, 2015

Childhood, young adult cancer survivors face high risk of long-term morbidity

November 20, 2015

UnitedHealth warns of marketplace exit: Start of a trend or push for White House action?

November 20, 2015

Practice Management

ASCO: Three-drug combo best for highly emetogenic chemotherapy

November 19, 2015

Patient & Survivor Care

Antibody drug conjugate induces responses in heavily pretreated TNBC

November 19, 2015

Breast Cancer

New bladder cancer drug fails first hurdle

November 19, 2015

Genitourinary Cancer

Myth of the Month: Does Colace work?

November 19, 2015

Immune-related events with checkpoint inhibitors are manageable

November 18, 2015

Study: Pediatric cancer patients have high rate of germline mutations in predisposition genes

November 18, 2015